Basal Cell Nevus Syndrome Clinical Trials

19 clinical trials for Basal Cell Nevus Syndrome across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Reproductive Options in Inherited Skin Diseases — RECRUITING
• Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling — RECRUITING
• Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study — RECRUITING
• Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma — COMPLETED · PHASE1
• Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome) — TERMINATED · PHASE3
• Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome) — COMPLETED · PHASE3
• Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor — COMPLETED · PHASE2
• To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS) — COMPLETED · PHASE2
• Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas — COMPLETED · PHASE2
• A PHASE 3, MUTLICENTER, OPEN-LABEL EXTENSION STUDY OF PATIDEGIB TROPICAL GEL, 2 % IN SUBJECTS WITH GORLIN SYNDROME (BASAL CELL NEVUS SYNDROME) — NOT_YET_RECRUITING · PHASE3
• Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome — COMPLETED · NA
• Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients — COMPLETED · PHASE2
• Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome — WITHDRAWN · PHASE2
• Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma — TERMINATED · PHASE2
• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, PHASE 3 EFFICACY AND SAFETY STUDY OF PATIDEGIB TOPICAL GEL, 2%, FOR THE REDUCTION OF DISEASE BURDEN OF PERSISTENTLY DEVELOPING BASAL CELL CARCINOMAS (BCCS) IN SUBJECTS WITH BASAL CELL NEVUS SYNDROME/PROTOCOL PELLE-926-301 — COMPLETED · PHASE3
• A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma — COMPLETED · PHASE1
• Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome — COMPLETED · NA
• EXTENSION PROTOCOL OF BMS-833923 IN SUBJECTS WITH BASAL CELL NEVUS SYNDROME — COMPLETED
• Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients — COMPLETED

Refine this search